Binningen, Switzerland

Anton Baumberger

USPTO Granted Patents = 2 



Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Anton Baumberger: Innovator in Pharmaceutical Compositions

Introduction

Anton Baumberger is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhalation therapies. With a total of 2 patents, his work focuses on improving the stability and efficacy of pharmaceutical compositions.

Latest Patents

Baumberger's latest patents include innovative processes for preparing dry powder formulations of glycopyrronium salt for inhalation. The first patent outlines a method that involves micronizing a glycopyrronium salt with an anti-adherent agent and admixing carrier particles to create a stable dry powder formulation. The second patent details a process for the micronization of pharmaceutically active agents, further enhancing the delivery of medications.

Career Highlights

Throughout his career, Anton Baumberger has been associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on developing advanced pharmaceutical solutions that address critical health needs.

Collaborations

Baumberger has collaborated with esteemed colleagues such as Wolfgang Wirth and Gerhard Muhrer. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Anton Baumberger's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through advanced formulations. His patents reflect a deep understanding of the complexities involved in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…